These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8566304)

  • 1. Effects of halothane on mu opioid binding in SH-SY5Y cells.
    Campbell DJ; Rowbotham DJ; Lambert DG
    Biochem Soc Trans; 1995 Aug; 23(3):416S. PubMed ID: 8566304
    [No Abstract]   [Full Text] [Related]  

  • 2. Do nitrous oxide and halothane influence opioid receptor binding in SH-SY5Y human neuroblastoma cells?
    Campbell DJ; Rowbotham DJ; Lambert DG
    Br J Anaesth; 1995 Dec; 75(6):752-5. PubMed ID: 8672325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the mu-opioid receptors on SH-SY5Y cells using beta-funaltrexamine (beta-FNA) and naloxonazine.
    Elliott J; Smart D; Traynor JR; Lambert DG
    Biochem Soc Trans; 1993 Nov; 21(4):469S. PubMed ID: 8132037
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
    Kramer HK; Simon EJ
    J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy.
    Emmerson PJ; Clark MJ; Medzihradsky F; Remmers AE
    J Neurochem; 1999 Jul; 73(1):289-300. PubMed ID: 10386982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine.
    Elliott J; Smart D; Lambert DG; Traynor JR
    Eur J Pharmacol; 1994 Aug; 268(3):447-50. PubMed ID: 7805771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
    Kramer HK; Simon EJ
    J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
    Weems HB; Chalecka-Franaszek E; Côté TE
    J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM; Mishra RK
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of opioid receptors in rat sensory neurons in culture.
    Chen JJ; Dymshitz J; Vasko MR
    Mol Pharmacol; 1997 Apr; 51(4):666-73. PubMed ID: 9106633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR; Nahorski SR
    Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for mu-, delta-, and kappa-opioid receptors in a human neuroblastoma cell line.
    Baumhaker Y; Wollman Y; Goldstein MN; Sarne Y
    Life Sci; 1993; 52(19):PL205-10. PubMed ID: 8387137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells.
    Horner KA; Zadina JE
    Brain Res; 2004 Dec; 1028(2):121-32. PubMed ID: 15527737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
    Breivogel CS; Selley DE; Childers SR
    J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification in the mu-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents.
    Gaibelet G; Capeyrou R; Dietrich G; Emorine LJ
    FEBS Lett; 1997 May; 408(2):135-40. PubMed ID: 9187354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent thermodynamic parameters of ligand binding to the cloned rat mu-opioid receptor.
    Li JG; Raffa RB; Cheung P; Tzeng TB; Liu-Chen LY
    Eur J Pharmacol; 1998 Aug; 354(2-3):227-37. PubMed ID: 9754924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line.
    Kampa M; Margioris AN; Hatzoglou A; Dermitzaki I; Denizot A; Henry JF; Oliver C; Gravanis A; Castanas E
    Eur J Pharmacol; 1999 Jan; 364(2-3):255-62. PubMed ID: 9932731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of opioid binding sites using selective antagonists.
    Lawrence AJ; Traynor JR
    Prog Clin Biol Res; 1990; 328():121-4. PubMed ID: 1968257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.